These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23548907)

  • 1. High-affinity cyclic peptide matriptase inhibitors.
    Quimbar P; Malik U; Sommerhoff CP; Kaas Q; Chan LY; Huang YH; Grundhuber M; Dunse K; Craik DJ; Anderson MA; Daly NL
    J Biol Chem; 2013 May; 288(19):13885-96. PubMed ID: 23548907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase.
    Long YQ; Lee SL; Lin CY; Enyedy IJ; Wang S; Li P; Dickson RB; Roller PP
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2515-9. PubMed ID: 11549459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
    Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
    J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold.
    Daly NL; Chen YK; Foley FM; Bansal PS; Bharathi R; Clark RJ; Sommerhoff CP; Craik DJ
    J Biol Chem; 2006 Aug; 281(33):23668-75. PubMed ID: 16766795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds.
    Gitlin-Domagalska A; Dębowski D; Łęgowska A; Stirnberg M; Okońska J; Gütschow M; Rolka K
    Biopolymers; 2017 Nov; 108(6):. PubMed ID: 28555756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
    Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
    Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
    Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V
    Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Matriptase-2 Based on the Trypsin Inhibitor SFTI-1.
    Gitlin A; Dębowski D; Karna N; Łęgowska A; Stirnberg M; Gütschow M; Rolka K
    Chembiochem; 2015 Jul; 16(11):1601-7. PubMed ID: 25999208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of catalytic domain of Matriptase in complex with Sunflower trypsin inhibitor-1.
    Yuan C; Chen L; Meehan EJ; Daly N; Craik DJ; Huang M; Ngo JC
    BMC Struct Biol; 2011 Jun; 11():30. PubMed ID: 21693064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
    de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
    Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitors of human matriptase-1 based on the scaffold of sunflower trypsin inhibitor.
    Fittler H; Avrutina O; Empting M; Kolmar H
    J Pept Sci; 2014 Jun; 20(6):415-20. PubMed ID: 24723440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors.
    Riley BT; Ilyichova O; de Veer SJ; Swedberg JE; Wilson E; Hoke DE; Harris JM; Buckle AM
    Biochemistry; 2019 May; 58(21):2524-2533. PubMed ID: 31058493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.
    Cascales L; Henriques ST; Kerr MC; Huang YH; Sweet MJ; Daly NL; Craik DJ
    J Biol Chem; 2011 Oct; 286(42):36932-43. PubMed ID: 21873420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif.
    Chen X; Riley BT; de Veer SJ; Hoke DE; Van Haeften J; Leahy D; Swedberg JE; Brattsand M; Hartfield PJ; Buckle AM; Harris JM
    PLoS One; 2019; 14(1):e0210842. PubMed ID: 30668585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized analogues of sunflower trypsin inhibitor-1 constitute a versatile group of affinity sorbents for selective isolation of serine proteases.
    Pereira HJ; Salgado MC; Oliveira EB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2039-44. PubMed ID: 19515617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural structural diversity within a conserved cyclic peptide scaffold.
    Elliott AG; Franke B; Armstrong DA; Craik DJ; Mylne JS; Rosengren KJ
    Amino Acids; 2017 Jan; 49(1):103-116. PubMed ID: 27695949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
    D'Souza C; Henriques ST; Wang CK; Craik DJ
    Eur J Med Chem; 2014 Dec; 88():10-8. PubMed ID: 24985034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
    Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
    J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity.
    Zabłotna E; Kret A; Jaśkiewicz A; Olma A; Leplawy MT; Rolka K
    Biochem Biophys Res Commun; 2006 Feb; 340(3):823-8. PubMed ID: 16380077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial tuning of peptidic drug candidates: high-affinity matriptase inhibitors through incremental structure-guided optimization.
    Fittler H; Avrutina O; Glotzbach B; Empting M; Kolmar H
    Org Biomol Chem; 2013 Mar; 11(11):1848-57. PubMed ID: 23361403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.